pharma sector : Latest News, Videos and Photos | Outlook Business
Home » Search
Search Result : "pharma sector"

The Nifty Pharma Index is down 27% over the past year amid pricing and regulatory pressure

With a mere 5% rise in sales in FY19, India’s auto industry is facing a challenging period

The pharma index has hugely underperformed the Sensex in CY17 owing to regulatory overhang and FDA issues 

Nilesh Shetty and Anand Shah on whether pharma stocks can make a comeback

Kotak Mahindra Bank MD & CEO Uday Kotak on the financial sector and the disruption in store

Over the past three years, the NSE Pharma Index has fallen 30% even as the benchmark Nifty rose 18%

Already grappling with falling sales in FY16, the auto sector has been further hit by measures in the Budget 

State-owned bank stocks have gained 30% in a month, post the recap announcement

The pharma major has made a few tough decisions over the past few years. Now, it’s beginning to pay off

The marquee private equity firm’s strategy of lending to growth companies and risky turnarounds has backfired badly, denting its reputation as a savvy financier

After establishing itself in the corporate insurance segment, Raheja QBE* wants to make inroads in retail insurance

The macro headwind may be getting worse for the infra sector, but a handful of companies with robust order book could just weather the dust storm

Thermax is a player in an unpredictable sector but CEO MS Unnikrishnan manages that by keeping a hawk-eye on cash flows

The US market remains choppy but Natco Pharma is becoming a compelling bet by rebooting itself with a new strategy

In Bottle of Lies: Ranbaxy and The Dark Side of Indian Pharma, Author Katherine Eban investigates the fall of Ranbaxy — a doom of its own making

The government’s decision to merge state-owned banks hardly provides a viable solution to key problems plaguing the sector

The Indian coal sector is facing growing risks on the back of oversupply and shift towards cleaner options

These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

Renewed governmental interest and private sector investment has brought back the spotlight on solar-based mini grids

Amid slow growth and poor governance in financial services, Kotak Mahindra Bank continues to steer ahead with a clear growth strategy

Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?

By integrating businesses seamlessly and scaling up prudently, DCM Shriram has done enviably well in an unpredictable sector

Despite the strong industry headwind, Torrent Pharma remains in the pink of health, thanks to its diversified geographical presence and specialty products

Solar Industries started off as an explosives trader in the eighties, but is now competing in the big league of defence supply